{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T06:29:08Z","timestamp":1772605748738,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T00:00:00Z","timestamp":1656979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T00:00:00Z","timestamp":1656979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer J."],"DOI":"10.1038\/s41408-022-00674-w","type":"journal-article","created":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T07:03:01Z","timestamp":1657004581000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Very late relapses in Hodgkin lymphoma treated with chemotherapy with or without radiotherapy: linear pattern and distinct prognostic factors"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8766-1853","authenticated-orcid":false,"given":"Theodoros P.","family":"Vassilakopoulos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evrydiki","family":"Kravvariti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3748-6142","authenticated-orcid":false,"given":"Fotios","family":"Panitsas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria K.","family":"Angelopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athanasios","family":"Liaskas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flora N.","family":"Kontopidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xanthoula","family":"Yiakoumis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleni","family":"Variami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria N.","family":"Dimopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina P.","family":"Siakantaris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John V.","family":"Asimakopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Arapaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8197-9895","authenticated-orcid":false,"given":"Maria","family":"Dimou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2692-5944","authenticated-orcid":false,"given":"Panagiotis","family":"Diamantopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sotirios","family":"Sachanas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chrysovalantou","family":"Chatzidimitriou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Belia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elianna","family":"Konstantinou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Boutsikas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyriaki","family":"Petevi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7400-5416","authenticated-orcid":false,"given":"Alexandros","family":"Kanellopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Styliani","family":"Kokoris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Christine","family":"Kyrtsonis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nora-Athina","family":"Viniou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleftheria","family":"Lakiotaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerasimos","family":"Tsourouflis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Penelope","family":"Korkolopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kostas","family":"Konstantopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panayiotis","family":"Panayiotidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerassimos A.","family":"Pangalis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,5]]},"reference":[{"key":"674_CR1","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/S0140-6736(15)60165-9","volume":"385","author":"CH Moskowitz","year":"2015","unstructured":"Moskowitz CH, Nademanee A, Masszi T, Agura E, Holowiecki J, Abidi MH, et al. Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin\u2019s lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2015;385:1853\u201362.","journal-title":"Lancet."},{"key":"674_CR2","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1200\/JCO.2015.65.4194","volume":"34","author":"G Hapgood","year":"2016","unstructured":"Hapgood G, Zheng Y, Sehn LH, Villa D, Klasa R, Gerrie AS, et al. Evaluation of the risk of relapse in classical Hodgkin lymphoma at event-free survival time points and survival comparison with the general population in British Columbia. J Clin Oncol. 2016;34:2493\u2013500.","journal-title":"J Clin Oncol"},{"key":"674_CR3","doi-asserted-by":"publisher","first-page":"292","DOI":"10.7326\/0003-4819-102-3-292","volume":"102","author":"TS Herman","year":"1985","unstructured":"Herman TS, Hoppe RT, Donaldson SS, Cox RS, Rosenberg SA, Kaplan HS. Late relapse among patients treated for Hodgkin\u2019s disease. Ann Intern Med. 1985;102:292\u20137.","journal-title":"Ann Intern Med"},{"key":"674_CR4","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1200\/JCO.1993.11.2.225","volume":"11","author":"S Bodis","year":"1993","unstructured":"Bodis S, Henry-Amar M, Bosq J, Burgers JM, Mellink WA, Dietrich PY, et al. Late relapse in early-stage Hodgkin\u2019s disease patients enrolled on European Organization for Research and Treatment of Cancer protocols. J Clin Oncol. 1993;11:225\u201332.","journal-title":"J Clin Oncol"},{"key":"674_CR5","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1002\/(SICI)1097-0142(19970401)79:7<1422::AID-CNCR20>3.0.CO;2-0","volume":"79","author":"JD Brierley","year":"1997","unstructured":"Brierley JD, Rathmell AJ, Gospodarowicz MK, Sutcliffe SB, Pintillie M. Late relapse after treatment for clinical stage I and II Hodgkin\u2019s disease. Cancer. 1997;79:1422\u20137.","journal-title":"Cancer."},{"key":"674_CR6","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1002\/(SICI)1097-0142(19980801)83:3<560::AID-CNCR26>3.0.CO;2-T","volume":"83","author":"R Garcia\u2010Carbonero","year":"1998","unstructured":"Garcia\u2010Carbonero R, Paz\u2010Ares L, Arcediano A, Lahuerta J, Bartolome A, Cortes\u2010Funes H. Favorable prognosis after late relapse of Hodgkin\u2019s disease. Cancer. 1998;83:562\u20135.","journal-title":"Cancer."},{"key":"674_CR7","first-page":"1686","volume":"51","author":"M Provencio","year":"2010","unstructured":"Provencio M, Salas C, Millan I, Cantos B, Sanchez A, Bellas C. Late relapses in Hodgkin lymphoma: a clinical and immunohistochemistry study. Leuk Lymphoma. 2010;51:1686\u201391.","journal-title":"Leuk Lymphoma"},{"key":"674_CR8","doi-asserted-by":"crossref","first-page":"707542","DOI":"10.1155\/2011\/707542","volume":"2011","author":"F Gaudio","year":"2011","unstructured":"Gaudio F, Giordano A, Pavone V, Perrone T, Curci P, Pastore D, et al. Outcome of very late relapse in patients with Hodgkin\u2019s lymphomas. Adv Hematol. 2011;2011:707542.","journal-title":"Adv Hematol"},{"key":"674_CR9","first-page":"481","volume":"22","author":"O Markovic","year":"2017","unstructured":"Markovic O, Andjelic B, Tarabar O, Todorovic M, Filipovic B, Stanisavljevic D, et al. Late relapse of Hodgkin\u2019s lymphoma\u2014is it different in clinical characteristics and outcome? J BUON. 2017;22:481\u20136.","journal-title":"J BUON"},{"key":"674_CR10","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s00432-018-2613-9","volume":"144","author":"L Pinczes","year":"2018","unstructured":"Pinczes L, Miltenyi Z, Illes A. Young adults diagnosed with Hodgkin lymphoma are at risk of relapsing late: a comprehensive analysis of late relapse in Hodgkin lymphoma. J Cancer Res Clin Oncol. 2018;144:935\u201343.","journal-title":"J Cancer Res Clin Oncol"},{"key":"674_CR11","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1182\/blood.V126.23.2697.2697","volume":"126","author":"S Viviani","year":"2015","unstructured":"Viviani S, Mussetti A, Di Bartolo O, Cabras A, Vlagussa P, Bonadonna G, et al. Late relapse in Hodgkin lymphoma (HL): a retrospective analysis of patients enrolled on clinical trials at the Istituto Nazionale Tumori of Milan (INT-MI). Blood. 2015;126:2697.","journal-title":"Blood"},{"key":"674_CR12","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1053\/j.seminhematol.2016.05.003","volume":"53","author":"PJ Brockelmann","year":"2016","unstructured":"Brockelmann PJ, Angelopoulou MK, Vassilakopoulos TP. Prognostic factors in Hodgkin lymphoma. Semin Hematol. 2016;53:155\u201364.","journal-title":"Semin Hematol"},{"key":"674_CR13","unstructured":"Vassilakopoulos TP, Liaskas A, Rizzuto G, Angelopoulou MK, Giatra H, Kontopidou FN, et al. Very late relapses (VLR) \u22655 years after initial treatment with chemotherapy \u00b1 radiotherapy (CT\u00b1RT) in Hodgkin lymphoma (HL): a joint study on treatment strategies and prognostic factors for the outcome. 24th Congress of EHA, June 13\u201316, Amsterdam, Netherlands, HemaSphere Abstract Book. 2019;3:187\u20138."},{"key":"674_CR14","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S0936-6555(05)80098-6","volume":"5","author":"KM Lee","year":"1993","unstructured":"Lee KM, Spittle MF. Hodgkin\u2019s disease: a case of late relapse. Clin Oncol. 1993;5:399.","journal-title":"Clin Oncol"},{"key":"674_CR15","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1097\/00000421-200112000-00009","volume":"24","author":"S Shihabi","year":"2001","unstructured":"Shihabi S, Deutsch M, Jacobs SA. Very late relapse of Hodgkin\u2019s disease: a report of five patients. Am J Clin Oncol. 2001;24:576\u20138.","journal-title":"Am J Clin Oncol"}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41408-022-00674-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-022-00674-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-022-00674-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T20:09:51Z","timestamp":1669234191000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41408-022-00674-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,5]]},"references-count":15,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7]]}},"alternative-id":["674"],"URL":"https:\/\/doi.org\/10.1038\/s41408-022-00674-w","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,5]]},"assertion":[{"value":"18 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"102"}}